Codependency of H2B Monoubiquitination and Nucleosome Reassembly on Chd1

Total Page:16

File Type:pdf, Size:1020Kb

Codependency of H2B Monoubiquitination and Nucleosome Reassembly on Chd1 Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press RESEARCH COMMUNICATION H3K79 trimethylation by Set1/COMPASS and Dot1, a pro- Codependency of H2B cess termed histone cross-talk (Dover et al. 2002; Sun and monoubiquitination and Allis 2002; Hwang et al. 2003; Wood et al. 2003a; Schneider et al. 2004; Smith and Shilatifard 2010). Other factors were nucleosome reassembly identified by GPS to be required for proper H3K4 and/or H3K79 methylation, including the Paf1 complex consist- on Chd1 ing of Paf1, Rtf1, Cdc73, and Ctr9 (Krogan et al. 2003; Jung-Shin Lee,1 Alexander S. Garrett,1 Wood et al. 2003b); the CTD kinases Bur1/Bur2 and Ctk1/ Ctk2/Ctk3 (Wood et al. 2005, 2007); the cell cycle regulator Kuangyu Yen,2 Yoh-Hei Takahashi,1 Deqing Hu,1 3 1 SBF (Schulze et al. 2009); and the N-terminal acetyl- Jessica Jackson, Christopher Seidel, transferase Ard1 (Takahashi et al. 2011). B. Franklin Pugh,2 and Ali Shilatifard1,4 Collectively, these studies using antibodies recognizing histone H3K4 and/or H3K79 methylation showed numer- 1Stowers Institute for Medical Research, Kansas City, Missouri 2 ous connections between the implementation of histone 64110, USA; Center for Eukaryotic Gene Regulation, H2B monoubiquitination and H3K4 methylation. In this Department of Biochemistry and Molecular Biology, The study, we used a recently generated antibody recognizing Pennsylvania State University, University Park, Pennsylvania 3 yeast H2B monoubiquitination and identified the chro- 16802, USA; Department of Biochemistry, St. Louis University matin remodeler Chd1 as a novel factor required for the School of Medicine, St. Louis, Missouri 63104, USA maintenance of high levels of histone H2B monoubiqui- tination. Importantly, the status of H3K4 and H3K79 Monoubiquitination of histone H2B on Lys 123 (H2BK123ub) methylation was unaffected in the chd1D background, is a transient histone modification considered to be essen- explaining why Chd1 was not identified in the earlier tial for establishing H3K4 and H3K79 trimethylation by GPS screens using H3K4- and H3K79-specific anti- Set1/COMPASS and Dot1, respectively. Here, we identified bodies. Despite the earlier studies suggesting integra- Chd1 as a factor that is required for the maintenance of tion of H2B monoubiquitination and H3 methylation high levels of H2B monoubiquitination, but not for H3K4 machineries, this study demonstrates that only low and H3K79 trimethylation. Loss of Chd1 results in a sub- levels of monoubiquitination are required for proper stantial loss of H2BK123ub levels with little to no effect on levels of H3K4 and H3K79 methylation. Also, recent the genome-wide pattern of H3K4 and H3K79 trimethyla- studies suggested other possible roles associated with histone H2B monoubiquitination, distinct from histone tion. Our data show that nucleosomal occupancy is reduced cross-talk (Pavri et al. 2006; Tanny et al. 2007; Fleming in gene bodies in both chd1D and, as has been shown, et al. 2008; Batta et al. 2011; Schulze et al. 2011), K123A mutant backgrounds. Wealsodemonstratedthat including effects on nucleosome positioning (Batta Chd1’s function in maintaining H2BK123ub levels is con- et al. 2011). We therefore used genome-wide expression served from yeast to humans. Our study provides evidence and nucleosome occupancy analysis in a chd1D strain that only small levels of H2BK123ub are necessary for full and a strain defective for H2B monoubiquitination and levels of H3K4 and H3K79 trimethylation in vivo and propose an evolutionarily conserved function for Chd1 points to a possible role for Chd1 in positively regulating in positively regulating gene expression through pro- gene expression through promoting nucleosome reas- moting nucleosome reassembly coupled with H2B sembly coupled with H2B monoubiquitination. monoubiquitination. Received January 9, 2012; revised version accepted March Results and Discussion 26, 2012. Loss of H2B monoubiquitination with normal levels of H3K4 and H3K79 methylation As fundamental components of chromatin, the histone Prior GPS screens using antibodies specific to either proteins are subjected to a variety of post-translational H3K4 or H3K79 methylation identified a requirement modifications that function in diverse processes (Bhaumik for numerous factors connected to H2B monoubiquitina- et al. 2007; Smith and Shilatifard 2010). In order to un- tion in proper H3 methylation (Smith and Shilatifard derstand the machinery that implements these modifica- 2010). Here, we instead performed a GPS-style screen tions and the cellular contexts in which they function, we with antibodies specific to histone H2B monoubiquitina- developed a biochemical screen called global proteomic tion and identified Chd1 as a novel factor required for analysis in Saccharomyces cerevisiae (GPS) (Schneider maintaining proper levels of histone H2B monoubiquiti- et al. 2004). This screen and other genetic screens identi- nation (Fig. 1A, lane 12). Although H2B monoubiquitina- fied numerous factors required for the proper implemen- tion levels are significantly reduced, H3K4 and H3K79 tation of different H3K4 and H3K79 methylation states. methylation levels were unchanged (Fig. 1B), indicating Notably, these include the histone H2B monoubiquitinase why Chd1 was not previously identified in screens probing complex Rad6/Bre1’s requirement for histone H3K4 and the methylation status of these residues. In the absence of Bre1, the E3 ligase required for H2B monoubiquitination by Rad6 (Wood et al. 2003a), we cannot detect any histone H2B [Keywords: chromatin; transcription; ubiquitination; histone] monoubiquitination or any histone H3K4 and/or H3K79 4Corresponding author. E-mail [email protected] trimethylation (Fig. 1B, lanes 7–10), validating the specific- Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.186841.112. ity of our antibodies. 914 GENES & DEVELOPMENT 26:914–919 Ó 2012 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/12; www.genesdev.org Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Chd1 and H2B monoubiquitination immunoprecipitation (ChIP) coupled with deep sequenc- ing (ChIP-seq) (Fig. 2A-C). Our data show that the global patterns of both H3K4 and H3K79 trimethylation were not significantly altered, although histone H2B mono- ubiquitination levels were decreased in these cells. An overview of the ChIP-seq signal on the entire ;230-kb chromosome I (Fig. 2A) indicates that the patterns of enrichment for the given histone marks are not grossly altered in level or intensity upon CHD1 deletion. In order to more quantitatively determine the extent of genome- wide changes in these marks, we computed an occupancy enrichment metric as the ratio of the sum of normalized read levels of each histone mark in the region of 6500 base pairs (bp) surrounding each gene start site divided by the normalized read sum of the associated whole-cell ex- tract control sample (input) in the same region. We then compared the occupancy enrichment ratios between the wild-type and chd1D strains for both marks (Fig. 2B,C) and found that the Pearson correlation coefficients for H3K4 Figure 1. Chd1 is required for the maintenance of high levels of and H3K79 trimethylation were 0.928 and 0.787, respec- H2B monoubiquitination but not H3K4 or H3K79 trimethylation. Cell extracts from the nonessential yeast gene deletion mutants tively. When we assessed only the normalized read sums were subjected to SDS-PAGE and analyzed by Western blotting surrounding gene start sites (without dividing by the using H2B monoubiquitination-specific antibodies. Lane H of plate whole-cell extract sample), both marks had a correlation #148 of the collection is shown in A. The red arrow indicates the coefficient >0.95 between the wild-type and chd1D strains. position in the plate containing the chd1D strain. The green arrow points to the empty well in the collection, used as the plate marker. (B) Cell extracts from wild-type (WT) and chd1D and bre1D strains Chd1, histone H2B monoubiquitination, nucleosomal were prepared and used in a titration analysis. Each extract was occupancy, and gene expression analyzed by its application to SDS-PAGE and tested for the presence of modified H3K4 and H3K79 mono-, di-, and trimethylation To determine the effect of the loss of Chd1 on overall gene (H3K4me1–3 and H3K79me1–3) and H2B monoubiquitination expression in yeast cells, we performed RNA sequencing (ubH2B) or total H4 using the appropriate antibodies. (C) A direct (RNA-seq) analyses in wild-type and chd1D strains (Fig. role for Chd1 in the regulation of histone H2B monoubiquitination 2D–G). We first checked the expression of the CHD1 was demonstrated by complementation of the chd1D strains with a vector carrying the CHD1 coding sequence under the GAL1 locus in the chd1D strain and confirmed that the deletion promoter. In the presence of galactose, Chd1 is expressed (shown resulted in complete loss of CHD1 expression (Fig. 2D). in lanes 7,8), as evident by Western signal with anti-Flag, and yeast Using an adjusted P-value threshold of 0.05, we found cells are restored for monoubiquitinated H2B. (D) CHD1 was also that 31 genes were down-regulated and 118 genes were deleted in a parental background that contains a sole copy of Flag- up-regulated after CHD1 deletion (Fig. 2E). A visual tagged histone H2B (to detect both wild-type and monoubiquitinated example of loss of expression for some highly expressed H2B). Extracts prepared from wild-type and chd1D strains were analyzed by SDS-PAGE and Western with the indicated antibodies. genes in the wild-type strain—namely, HOM3 (Fig. 2F) and ARN2—are shown (Fig. 2G). Our RNA-seq studies and a recent microarray study on the gene expression We confirmed a specific role for Chd1 in regulating regulatory and nucleosome organization function of Chd1 histone H2B monoubiquitination levels by complement- (Gkikopoulos et al. 2011) demonstrate that the expression ing the chd1D strain with a vector carrying FlagTCHD1 of very few genes are altered in the absence of Chd1. under the GAL1 promoter (Fig.
Recommended publications
  • Architecture of the RNA Polymerase II-Paf1c-TFIIS Transcription Elongation Complex
    Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München Architecture of the RNA polymerase II- Paf1C-TFIIS transcription elongation complex Youwei Xu aus Gaoyou, Jiangsu Provinz, P.R.China 2016 Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München Architecture of the RNA polymerase II- Paf1C-TFIIS transcription elongation complex Youwei Xu aus Gaoyou, Jiangsu Provinz, P.R.China 2016 Erklärung Diese Dissertation wurde im Sinne von § 7 der Promotionsordnung vom 28. November 2011 von Herrn Prof. Dr. Patrick Cramer betreut. Eidesstattliche Versicherung Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet. Göttingen, den 28.11.2016 Youwei Xu Dissertation eingereicht am 01.12.2016 1. Gutachter: Prof. Dr. Patrick Cramer 2. Gutachter: PD Dr. Dietmar Martin Mündliche Prüfung am 25.01.2017 "My apologies to great questions for small answers." - Wislawa Szymborska Acknowledgements Firstly, I would like to express my sincere gratitude to Patrick Cramer for giving me such a great opportunity to study in this lab. This is an excellent lab circumstanced by outstanding scientific atmosphere. I still remember that you asked me whether I had further questions for you at the end of our interview via the phone, I asked how about the weather in Munich. I feel very lucky being your student. You always gave me fantastic suggestions, sufficient support, and enough patience. I learned a lot from you, and your enthusiasm for science and life inspires me. I am most indebted to my past and present colleagues of the Cramer group from Munich and Göttingen for the great assistance, stimulating discussions, advice, encouragement, and joyful life, especially the following people: Carrie Bernecky, Christoph Engel, Simon Neyer, Christian Dienemann, Clemens Plaschka, Sarah Sainsbury, Merle Hantsche, Anna Sawicka, Jinmi Choi, Carina Demel, Margaux Michel, Tobias Gubbey, Dimitry Tengunov, and Sara Osman.
    [Show full text]
  • Recombinant CHD1 Protein
    Recombinant CHD1 protein Catalog No: 81307, 81607 Quantity: 20, 1000 µg Expressed In: Baculovirus Concentration: 0.4 µg/µl Source: Human Buffer Contents: Recombinant CHD1 protein is supplied in 25 mM HEPES-NaOH pH 7.5, 300 mM NaCl, 10% glycerol, 0.04% Triton X-100, and 0.5 mM TCEP. Background: CHD1 (Chromodomain Helicase DNA Binding Protein 1) is one of the CHD family proteins. They are characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD1 is a ATP-dependent chromatin-remodeling factor which functions as substrate recognition component of the transcription regulatory histone acetylation (HAT) complex SAGA. It can regulate polymerase II transcription, and is also required for efficient transcription by RNA polymerase I, and more specifically the polymerase I transcription termination step. CHD1 is not only involved in transcription-related chromatin-remodeling, but also required to maintain a specific chromatin configuration across the genome. It is required for the bridging of SNF2, the FACT complex, the PAF complex as well as the U2 snRNP complex to H3K4me3. Protein Details: Full length CHD1 protein (accession number AAI17135.1) was expressed in a baculovirus system with an N-terminal FLAG-Tag. The molecular weight of the protein is 197.9 kDa. Recombinant CHD1 protein gel Application Notes: This product was manufactured as described in Protein Details. 7.5% SDS-PAGE gel with Where possible, Active Motif has developed functional or activity assays for Coomassie blue staining recombinant proteins. Additional characterization such as enzyme kinetic activity assays, inhibitor screening or other biological activity assays may not have been MW: 197.9 kDa performed for every product.
    [Show full text]
  • Molecular Evolution of the Avian CHD1 Genes on the Z and W Sex Chromosomes
    Copyright 2000 by the Genetics Society of America Molecular Evolution of the Avian CHD1 Genes on the Z and W Sex Chromosomes Anna-Karin Fridolfsson and Hans Ellegren Department of Evolutionary Biology, Evolutionary Biology Centre, Uppsala University, SE-752-36 Uppsala, Sweden Manuscript received December 8, 1999 Accepted for publication April 14, 2000 ABSTRACT Genes shared between the nonrecombining parts of the two types of sex chromosomes offer a potential means to study the molecular evolution of the same gene exposed to different genomic environments. We have analyzed the molecular evolution of the coding sequence of the ®rst pair of genes found to be shared by the avian Z (present in both sexes) and W (female-speci®c) sex chromosomes, CHD1Z and CHD1W. We show here that these two genes evolve independently but are highly conserved at nucleotide as well as amino acid levels, thus not indicating a female-speci®c role of the CHD1W gene. From comparisons of sequence data from three avian lineages, the frequency of nonsynonymous substitutions (Ka) was found to be higher for CHD1W (1.55 per 100 sites) than for CHD1Z (0.81), while the opposite was found for synonymous substitutions (Ks, 13.5 vs. 22.7). We argue that the lower effective population size and the absence of recombination on the W chromosome will generally imply that nonsynonymous substitutions accumulate faster on this chromosome than on the Z chromosome. The same should be true for the Y chromosome relative to the X chromosome in XY systems. Our data are compatible with a male-biased mutation rate, manifested by the faster rate of neutral evolution (synonymous substitutions) on the Z chromosome than on the female-speci®c W chromosome.
    [Show full text]
  • CHD1 Loss Negatively Influences Metastasis-Free Survival in R0
    Cancer Gene Therapy https://doi.org/10.1038/s41417-020-00288-z ARTICLE CHD1 loss negatively influences metastasis-free survival in R0- resected prostate cancer patients and promotes spontaneous metastasis in vivo 1,2 2 1,2 3 4 2 Su Jung Oh-Hohenhorst ● Derya Tilki ● Ann-Kristin Ahlers ● Anna Suling ● Oliver Hahn ● Pierre Tennstedt ● 1 1 1 1 1 5,8 Christiane Matuszcak ● Hanna Maar ● Vera Labitzky ● Sandra Hanika ● Sarah Starzonek ● Simon Baumgart ● 6 7 7 7 7 2 Steven A. Johnsen ● Martina Kluth ● Hüseyin Sirma ● Ronald Simon ● Guido Sauter ● Hartwig Huland ● 1 1 Udo Schumacher ● Tobias Lange Received: 21 September 2020 / Revised: 9 December 2020 / Accepted: 10 December 2020 © The Author(s) 2021. This article is published with open access Abstract The outcome of prostate cancer (PCa) patients is highly variable and depends on whether or not distant metastases occur. Multiple chromosomal deletions have been linked to early tumor marker PSA recurrence (biochemical relapse, BCR) after radical prostatectomy (RP), but their potential role for distant metastasis formation is largely unknown. Here, we 1234567890();,: 1234567890();,: specifically analyzed whether deletion of the tumor suppressor CHD1 (5q21) influences the post-surgical risk of distant metastasis and whether CHD1 loss directly contributes to metastasis formation in vivo. By considering >6800 patients we found that the CHD1 deletion negatively influences metastasis-free survival in R0 patients (HR: 2.32; 95% CI: 1.61, 3.33; p < 0.001) independent of preoperative PSA, pT stage, pN status, Gleason Score, and BCR. Moreover, CHD1 deletion predicts shortened BCR-free survival in pT2 patients and cancer-specific survival in all patients.
    [Show full text]
  • Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Defi Cient Prostate Cancer
    Published OnlineFirst May 8, 2020; DOI: 10.1158/2159-8290.CD-19-1352 RESEARCH ARTICLE Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Defi cient Prostate Cancer Di Zhao 1 , 2 , Li Cai 1 , Xin Lu 1 , 3 , Xin Liang 1 , 4 , Jiexi Li 1 , Peiwen Chen 1 , Michael Ittmann 5 , Xiaoying Shang 1 , Shan Jiang6 , Haoyan Li 2 , Chenling Meng 2 , Ivonne Flores 6 , Jian H. Song 4 , James W. Horner 6 , Zhengdao Lan 1 , Chang-Jiun Wu6 , Jun Li 6 , Qing Chang 7 , Ko-Chien Chen 1 , Guocan Wang 1 , 4 , Pingna Deng 1 , Denise J. Spring 1 , Y. Alan Wang1 , and Ronald A. DePinho 1 Downloaded from cancerdiscovery.aacrjournals.org on September 28, 2021. © 2020 American Association for Cancer Research. Published OnlineFirst May 8, 2020; DOI: 10.1158/2159-8290.CD-19-1352 ABSTRACT Genetic inactivation of PTEN is common in prostate cancer and correlates with poorer prognosis. We previously identifi edCHD1 as an essential gene in PTEN- defi cient cancer cells. Here, we sought defi nitivein vivo genetic evidence for, and mechanistic under- standing of, the essential role of CHD1 in PTEN-defi cient prostate cancer. In Pten and Pten /Smad4 genetically engineered mouse models, prostate-specifi c deletion ofChd1 resulted in markedly delayed tumor progression and prolonged survival. Chd1 deletion was associated with profound tumor microenvironment (TME) remodeling characterized by reduced myeloid-derived suppressor cells (MDSC) and increased CD8+ T cells. Further analysis identifi ed IL6 as a key transcriptional target of CHD1, which plays a major role in recruitment of immunosuppressive MDSCs.
    [Show full text]
  • Dynamic Landscape of Chromatin Accessibility and Transcriptomic
    www.nature.com/scientificreports OPEN Dynamic landscape of chromatin accessibility and transcriptomic changes during diferentiation of human embryonic stem cells into dopaminergic neurons César Meléndez‑Ramírez1,2,6, Raquel Cuevas‑Diaz Duran3,6*, Tonatiuh Barrios‑García3, Mayela Giacoman‑Lozano3, Adolfo López‑Ornelas1,2,4, Jessica Herrera‑Gamboa3, Enrique Estudillo2, Ernesto Soto‑Reyes5, Iván Velasco1,2* & Víctor Treviño3* Chromatin architecture infuences transcription by modulating the physical access of regulatory factors to DNA, playing fundamental roles in cell identity. Studies on dopaminergic diferentiation have identifed coding genes, but the relationship with non‑coding genes or chromatin accessibility remains elusive. Using RNA‑Seq and ATAC‑Seq we profled diferentially expressed transcripts and open chromatin regions during early dopaminergic neuron diferentiation. Hierarchical clustering of diferentially expressed genes, resulted in 6 groups with unique characteristics. Surprisingly, the abundance of long non‑coding RNAs (lncRNAs) was high in the most downregulated transcripts, and depicted positive correlations with target mRNAs. We observed that open chromatin regions decrease upon diferentiation. Enrichment analyses of accessibility depict an association between open chromatin regions and specifc functional pathways and gene‑sets. A bioinformatic search for motifs allowed us to identify transcription factors and structural nuclear proteins that potentially regulate dopaminergic diferentiation. Interestingly, we also found changes in protein and mRNA abundance of the CCCTC‑binding factor, CTCF, which participates in genome organization and gene expression. Furthermore, assays demonstrated co‑localization of CTCF with Polycomb‑repressed chromatin marked by H3K27me3 in pluripotent cells, progressively decreasing in neural precursor cells and diferentiated neurons. Our work provides a unique resource of transcription factors and regulatory elements, potentially involved in the acquisition of human dopaminergic neuron cell identity.
    [Show full text]
  • Structural Reorganization of the Chromatin Remodeling Enzyme
    RESEARCH ARTICLE Structural reorganization of the chromatin remodeling enzyme Chd1 upon engagement with nucleosomes Ramasubramanian Sundaramoorthy1, Amanda L Hughes1, Vijender Singh1, Nicola Wiechens1, Daniel P Ryan1†, Hassane El-Mkami2, Maxim Petoukhov3, Dmitri I Svergun3, Barbara Treutlein4‡, Salina Quack4, Monika Fischer4, Jens Michaelis4, Bettina Bo¨ ttcher5, David G Norman6, Tom Owen-Hughes1* 1Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom; 2School of Physics and Astronomy, University of St Andrews, St Andrews, United Kingdom; 3Hamburg Outstation, European Molecular Biology Laboratory, Hamburg, Germany; 4Institute for Biophysics, Faculty of Natural Sciences, Ulm University, Ulm, Germany; 5Lehrstuhl fu¨ r Biochemie, Rudolf-Virchow Zentrum, Universitat Wu¨ rzburg, Wu¨ rzburg, Germany; 6Nucleic Acids Structure Research Group, University of Dundee, Dundee, United Kingdom Abstract The yeast Chd1 protein acts to position nucleosomes across genomes. Here, we model *For correspondence: t.a. the structure of the Chd1 protein in solution and when bound to nucleosomes. In the apo state, the [email protected] DNA-binding domain contacts the edge of the nucleosome while in the presence of the non- Present address: †Department hydrolyzable ATP analog, ADP-beryllium fluoride, we observe additional interactions between the of Genome Sciences, The John ATPase domain and the adjacent DNA gyre 1.5 helical turns from the dyad axis of symmetry. Curtin School of Medical Binding in this conformation involves unravelling the outer turn of nucleosomal DNA and requires Research, The Australian substantial reorientation of the DNA-binding domain with respect to the ATPase domains. The National University, Canberra, orientation of the DNA-binding domain is mediated by sequences in the N-terminus and mutations Australia; ‡Max Planck Institute to this part of the protein have positive and negative effects on Chd1 activity.
    [Show full text]
  • A Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic Buffering of Doxorubicin Sean M
    Santos and Hartman Cancer & Metabolism (2019) 7:9 https://doi.org/10.1186/s40170-019-0201-3 RESEARCH Open Access A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin Sean M. Santos and John L. Hartman IV* Abstract Background: The influence of the Warburg phenomenon on chemotherapy response is unknown. Saccharomyces cerevisiae mimics the Warburg effect, repressing respiration in the presence of adequate glucose. Yeast phenomic experiments were conducted to assess potential influences of Warburg metabolism on gene-drug interaction underlying the cellular response to doxorubicin. Homologous genes from yeast phenomic and cancer pharmacogenomics data were analyzed to infer evolutionary conservation of gene-drug interaction and predict therapeutic relevance. Methods: Cell proliferation phenotypes (CPPs) of the yeast gene knockout/knockdown library were measured by quantitative high-throughput cell array phenotyping (Q-HTCP), treating with escalating doxorubicin concentrations under conditions of respiratory or glycolytic metabolism. Doxorubicin-gene interaction was quantified by departure of CPPs observed for the doxorubicin-treated mutant strain from that expected based on an interaction model. Recursive expectation-maximization clustering (REMc) and Gene Ontology (GO)-based analyses of interactions identified functional biological modules that differentially buffer or promote doxorubicin cytotoxicity with respect to Warburg metabolism. Yeast phenomic and cancer pharmacogenomics data were integrated to predict differential gene expression causally influencing doxorubicin anti-tumor efficacy. Results: Yeast compromised for genes functioning in chromatin organization, and several other cellular processes are more resistant to doxorubicin under glycolytic conditions. Thus, the Warburg transition appears to alleviate requirements for cellular functions that buffer doxorubicin cytotoxicity in a respiratory context.
    [Show full text]
  • CHD1 Motor Protein Is Required for Deposition of Histone Variant H3.3
    REPORTS sions, Df(2L)Chd1[1] and Df(2L)Chd1[2], deleted CHD1 Motor Protein Is Required for fragments of the Chd1 gene and fragments of unrelated adjacent genes. Heterozygous combi- nations, however, of Chd1[1] or Chd1[2] with Deposition of Histone Variant Df(2L)Exel7014 affect both copies of the Chd1 gene only (Fig. 1B). We also identified a single H3.3 into Chromatin in Vivo point mutation that results in premature translation termination of Chd1 (Q1394*) in a previously 1 2 3 2 4 Alexander Y. Konev, Martin Tribus, Sung Yeon Park, Valerie Podhraski, Chin Yan Lim, * described lethal allele, l(2)23Cd[A7-4] (11). 1 1 3 4 Alexander V. Emelyanov, Elena Vershilova, Vincenzo Pirrotta, James T. Kadonaga, Hence, l(2)23Cd[A7-4] was renamed Chd1[3]. 2 1 Alexandra Lusser, † Dmitry V. Fyodorov † Analysis of Western blots of embryos from heterozygous Chd1[3] fruit flies revealed the The organization of chromatin affects all aspects of nuclear DNA metabolism in eukaryotes. H3.3 is an presence of a truncated polypeptide besides full- evolutionarily conserved histone variant and a key substrate for replication-independent chromatin length CHD1 (Fig. 1C). No truncated polypep- assembly. Elimination of chromatin remodeling factor CHD1 in Drosophila embryos abolishes tides were detected in heterozygous Chd1[1] or incorporation of H3.3 into the male pronucleus, renders the paternal genome unable to participate in Chd1[2] embryos. Therefore, the corresponding zygotic mitoses, and leads to the development of haploid embryos. Furthermore, CHD1, but not ISWI, deficiencies result in null mutations of Chd1.
    [Show full text]
  • Synthetic Essentiality of Chromatin Remodelling Factor CHD1 in PTEN
    LETTER doi:10.1038/nature21357 Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer Di Zhao1, Xin Lu1*, Guocan Wang1*, Zhengdao Lan1, Wenting Liao1, Jun Li2, Xin Liang1, Jasper Robin Chen1, Sagar Shah1, Xiaoying Shang1, Ming Tang2, Pingna Deng1, Prasenjit Dey1, Deepavali Chakravarti1, Peiwen Chen1, Denise J. Spring1, Nora M. Navone4, Patricia Troncoso5, Jianhua Zhang2, Y. Alan Wang1 & Ronald A. DePinho1 Synthetic lethality and collateral lethality are two well-validated identifying functional interactions of components in specific pathways conceptual strategies for identifying therapeutic targets in cancers that show mutually exclusive patterns of genomic alterations. Such with tumour-suppressor gene deletions1–3. Here, we explore an epistatic patterns include components of the retinoblastoma (Rb) or approach to identify potential synthetic-lethal interactions by p53 pathways, in which alterations in one gene in the pathway typ- screening mutually exclusive deletion patterns in cancer genomes. ically alleviates genetic pressure to alter another driver in the same We sought to identify ‘synthetic-essential’ genes: those that are pathway, consistent with minimal additional selective advantage to occasionally deleted in some cancers but are almost always retained the cancer cell9,10. in the context of a specific tumour-suppressor deficiency. We also Using The Cancer Genome Atlas (TCGA) database, we sought to posited that such synthetic-essential genes would be therapeutic establish and validate an approach
    [Show full text]
  • Structure of the Chromatin Remodelling Enzyme Chd1 Bound to A
    RESEARCH ARTICLE Structure of the chromatin remodelling enzyme Chd1 bound to a ubiquitinylated nucleosome Ramasubramanian Sundaramoorthy1, Amanda L Hughes1, Hassane El-Mkami2, David G Norman3, Helder Ferreira4, Tom Owen-Hughes1* 1Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom; 2School of Physics and Astronomy, University of St Andrews, St Andrews, United Kingdom; 3Nucleic Acids Structure Research Group, University of Dundee, Dundee, United Kingdom; 4School of Biology, University of St Andrews, St Andrews, United Kingdom Abstract ATP-dependent chromatin remodelling proteins represent a diverse family of proteins that share ATPase domains that are adapted to regulate protein–DNA interactions. Here, we present structures of the Saccharomyces cerevisiae Chd1 protein engaged with nucleosomes in the presence of the transition state mimic ADP-beryllium fluoride. The path of DNA strands through the ATPase domains indicates the presence of contacts conserved with single strand translocases and additional contacts with both strands that are unique to Snf2 related proteins. The structure provides connectivity between rearrangement of ATPase lobes to a closed, nucleotide bound state and the sensing of linker DNA. Two turns of linker DNA are prised off the surface of the histone octamer as a result of Chd1 binding, and both the histone H3 tail and ubiquitin conjugated to lysine 120 are re-orientated towards the unravelled DNA. This indicates how changes to nucleosome structure can alter the way in which histone epitopes are presented. DOI: https://doi.org/10.7554/eLife.35720.001 *For correspondence: [email protected] Introduction Competing interests: The The extended family of ATPases related to the yeast Snf2 protein acts to alter DNA-protein interac- authors declare that no tions (Flaus et al., 2006; Narlikar et al., 2013).
    [Show full text]
  • I STRUCTURAL and FUNCTIONAL CHARACTERIZATION of RTF1
    STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF RTF1 AND INSIGHT INTO ITS ROLE IN TRANSCRIPTIONAL REGULATION by Adam Douglas Wier B.S., Molecular Biology and Biochemistry, Lebanon Valley College, 2009 Submitted to the Graduate Faculty of the Kenneth P. Dietrich School of Arts and Sciences in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2014 i UNIVERSITY OF PITTSBURGH KENNETH P. DIETRICH SCHOOL OF ARTS AND SCIENCES This dissertation was presented by Adam D. Wier It was defended on August 20, 2014 and approved by James M. Pipas, Ph.D., Professor, Biological Sciences Karen M. Arndt, Ph.D., Professor, Biological Sciences John M Rosenberg, Ph.D., Professor, Biological Sciences Martin C. Schmidt, Ph.D., Associate Professor, Microbiology and Molecular Genetics Committee Chair: Andrew P. VanDemark, Ph.D., Associate Professor, Biological Sciences ii Copyright © by Adam D. Wier 2014 iii STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF RTF1 AND INSIGHT INTO ITS ROLE IN TRANSCRIPTIONAL REGULATION Adam D. Wier, PhD University of Pittsburgh, 2014 Originally discovered in a search for RNA polymerase II-associated factors, the Paf1 complex (Paf1C) is best characterized for its roles in regulating transcription elongation. The complex co- localizes with RNA polymerase II from the promoter to the 3’ end of genes and has been linked to a growing list of transcription-related processes including: elongation through chromatin, histone modifications, and recruitment of factors important in transcript maturation. The complex is conserved throughout eukaryotes and is comprised of the proteins Paf1, Ctr9, Cdc73, Rtf1, and Leo1. The domain structures of Paf1C subunits are largely undefined and have few clear homologs, making it difficult to postulate for or localize functions to the individual subunits.
    [Show full text]